1. Home
  2. List
Reference Patent

Reference - List

  • 672 Hits
  • Search Condition : Filter (MeSH = Gene Expression Regulation, Neoplastic)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) METTL3-mediated m6A methylation on lncRNA H19 inhibits intrahepatic cholangiocarcinoma progression through PPARγ downregulation.
Human and Animal Cells Lu-134-A(RCB0466) Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer.
Human and Animal Cells LoVo(RCB1639) , HCT116(RCB2979) , CACO-2(RCB0988) Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
Human and Animal Cells WiDr-TC(RCB1908) , COLO205(RCB2127) Protein phosphatase 6 promotes stemness of colorectal cancer cells.
Human and Animal Cells MKN28(RCB1000) , MKN45(RCB1001) CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancer.
Human and Animal Cells TE-6(RCB1950) Zinc Finger Protein 82 regulates p53 protein stability through histone deacetylase and enhances neo-adjuvant chemotherapy in esophageal cancer.
Human and Animal Cells A431(RCB0202) IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells.
DNA material tFucci(CA)2/pCSII-EF (RDB15446) A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes.
Human and Animal Cells HuH-7(RCB1366) , OS-RC-2(RCB0735) Deciphering the role of the MALT1-RC3H1 axis in regulating GPX4 protein stability.
Human and Animal Cells TE-5(RCB1949) , TE-4(RCB2097) , TE-8(RCB2098) , TE-11(RCB2100) miR‑100‑5p and miR‑203a‑3p suppress esophageal squamous cell carcinoma progression by targeting FKBP5.
Human and Animal Cells CACO-2(RCB0988) , KP4(RCB1005) AMIGO2 accelerates tumor progression by inducing a cancer stem cell-like phenotype.
Human and Animal Cells TE-6(RCB1950) , TE-10(RCB2099) High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance.
Human and Animal Cells TE-5(RCB1949) , TE-8(RCB2098) , TE-9(RCB1988) , TE-15(RCB1951) Low levels of tumor suppressor miR-3619 in plasma contribute to malignant outcomes and a target for nucleic acid therapy in esophageal cancer.
Human and Animal Cells MCF7(RCB1904) , SK-BR-3(RCB2132) Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC).
Human and Animal Cells Raji PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.
Human and Animal Cells HSC-4(RCB1902) , Sa3(RCB0980) , HSQ-89(RCB0789) , SAS(RCB1974) , Ca9-22(RCB1976) Long non-coding RNA taurine upregulated 1 regulates the progression of head and neck cancer.
Human and Animal Cells TGBC1TKB(RCB1129) Unveiling the causative role of promoter variant rs113823671 in MMP7 in gallbladder cancer susceptibility.
Human and Animal Cells 293T(RCB2202) , MG-63(RCB1890) PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3.
Human and Animal Cells HuCCT1(RCB1960) A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs.
Human and Animal Cells NIH:OVCAR-3(RCB2135) Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer.